Immediate Impact
50 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Mamoru Narukawa being referenced
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mamoru Narukawa | 178 | 61 | 53 | 97 | 81 | 107 | 600 | |
| Masayuki Kaneko | 80 | 11 | 26 | 116 | 120 | 77 | 717 | |
| Giuseppe Roberto | 80 | 25 | 13 | 34 | 183 | 50 | 699 | |
| Alessandro Chinellato | 93 | 7 | 15 | 102 | 95 | 64 | 637 | |
| Rolin L. Wade | 131 | 12 | 7 | 46 | 103 | 80 | 611 | |
| S. Yokoyama | 29 | 46 | 3 | 155 | 50 | 67 | 647 | |
| Maxine D. Fisher | 125 | 12 | 8 | 58 | 193 | 52 | 716 | |
| Yilin Chen | 21 | 18 | 61 | 115 | 57 | 51 | 644 | |
| Krishnan Ramaswamy | 47 | 5 | 37 | 70 | 53 | 66 | 667 | |
| William B. Feldman | 218 | 35 | 15 | 28 | 40 | 75 | 565 | |
| Jetty A. Overbeek | 41 | 8 | 8 | 132 | 113 | 57 | 673 |
All Works
Login with ORCID to disown or claim papers
Loading papers...